IFNG and glioblastoma: These findings suggest that CAR‐T cell therapy can transform the TME, supporting the activation of endogenous anti‐tumor immunity and highlighting the critical role of IFN‐γ signaling in the success of CAR‐T cell therapy for GBM [97].